Results 11 to 20 of about 58,451 (152)
Biomarkers in Heart Failure with Preserved Ejection Fraction
Cardiac Failure Review, 2022 Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological mechanisms.
Antoni Bayes-Genis +5 more
doaj +5 more sources
Treatment of heart failure with preserved ejection fraction
Monaldi Archives for Chest Disease, 2018 Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources.
Alfredo Monteverde +4 more
doaj +7 more sources
Heart failure with preserved ejection fraction [PDF]
Pflügers Archiv - European Journal of Physiology, 2014 Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with preserved ejection fraction (HFpEF) is emerging as the most common form of HF.
James D, Gladden +2 more
+9 more sources
Heart Failure with Preserved Ejection Fraction [PDF]
New England Journal of Medicine, 2016 Heart failure with preserved ejection fraction and sex differences.
Jonathan R, Dalzell, Kirsty M, McDowell
+15 more sources
Heart failure with preserved ejection fraction [PDF]
Tidsskrift for Den norske legeforening, 2017 Half of all heart failure patients have preserved ejection fraction, but there is no established therapy for this patient group. Effective heart failure therapy depends on an understanding of the underlying pathophysiology. This article presents an updated review of knowledge on the causal mechanisms underlying heart failure with preserved ejection ...
Åsmund Treu, Røe +2 more
openaire +2 more sources
Heart failure with preserved ejection fraction [PDF]
Clinical Medicine, 2018 Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection of conditions that are unified by the presence of a left ventricular ejection fraction ≥50%, evidence of impaired diastolic function and elevated natriuretic peptide levels, all within the context of typical heart failure signs and symptoms.
Harper, AR, Patel, HC, Lyon, AR
openaire +4 more sources
Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure [PDF]
Zhongguo quanke yixue, 2022 The American Heart Association (AHA) , American College of Cardiology (ACC) and Heart Failure Society of America (HFSA) jointly released the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (hereinafter referred to as the 2022 Guideline) .
Yifang GUO
doaj +1 more source
Frontiers in Immunology, 2022 The incidence of heart failure with preserved ejection fraction is increasing in patients with obesity, diabetes, hypertension, and in the aging population. However, there is a lack of adequate clinical treatment.
Chenyu Li +5 more
doaj +1 more source
Zaporožskij Medicinskij Žurnal, 2023 Chronic heart failure remains one of the main causes of mortality and reduced life quality both in Ukraine and around the world. More than 50 % of all patients with chronic heart failure are those with preserved left ventricular ejection fraction.
Ya. Yu. Maistrovych, M. Yu. Kolesnyk
doaj +1 more source
Women's Health, 2022 Heart failure with preserved ejection fraction has a higher prevalence in women versus men. There are several proposed mechanisms to explain this sex discrepancy including differences in cardiovascular adaptation to comorbidities and potential underlying
Gurleen Kaur, Emily Lau
doaj +1 more source